• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Design and Synthetic Development of New Multifunctional Anti-cancer Agents

Research Project

Project/Area Number 60470146
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Chemical pharmacy
Research InstitutionKyoto University

Principal Investigator

NAGAO Yoshimitsu  Institute for Chemical Research, Kyoto University, 化学研究所, 助教授 (40027074)

Co-Investigator(Kenkyū-buntansha) OCHIAI Masahito  Institute for Chemical Research, Kyoto University, 化学研究所, 助手 (50127065)
NODE Manabu  Institute for Chemical Research, Kyoto University, 化学研究所, 助教授 (60027076)
FUJI Kaoru  Institute for Chemical Research, Kyoto University, 化学研究所, 教授 (20027056)
Project Period (FY) 1985 – 1986
Project Status Completed (Fiscal Year 1986)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1986: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1985: ¥1,600,000 (Direct Cost: ¥1,600,000)
Keywordsmultifunctional anti-cancer agent / thiazolidine-2-thione carboxylic acid / nitrofurazane / nitrotriazole / nitroimidazole / oridonin / aldose reductase inhibitor / diabetes / radiosencitizer
Research Abstract

1) We designed a guideline for the development of new multifunctional anti-cancer agents based on much information on the thiol chemistry, DNA-binding drugs, the relationship between chemical structure and toxicity, and radiosencitizing chemistry of DNA.
2) According to our own guideline, we synthesized various thiazolidine-2-thiones, nitrofurazanes, 3-nitrotriazoles, and 2-nitroimidazoles, respectively. These new compounds and a Rabdosia diterpenoid, oridonin, were subjected to biological screening tests in vitro and in vivo system. From the results, the following facts were disclosed. Some thiazolidine-2-thione carboxylic acids having a weak immuno activity, exhibited fairly strong aldose reductase inhibition being concerned with the therapeutic agents for the chronic complications of diabetes. Nitrofurazanes, 3-nitrotriazoles, and 2-nitroimidazoles would be hopeful radiosencitizers in cancer radiotherapy. A tumor-inhibitor, oridonin showed an additive effect on the radiosencitizing activities of misonidazole to hypoxic cells. Thus, oridonin may be available for cancer radiotherapy.
3) In order to clarify active mechanism of a clinically useful anti-cancer drugs: camptotecin derivatives and bleomycin A2, polyamine-containing radiosencitizers, and benzo[C]-phenanthridine alkaloids, interaction between drugs and DNA was investigated utilizing the Tm measurement, UV difference spectum, and <^1H> - and <^(13)C> -NMR spectrum. It was revealed that benzo[C]-phenanthridine alkaloids clearly form strong charge-transfer complexes with the nucleic bases in double and and single strand DNA.

Report

(1 results)
  • 1986 Final Research Report Summary
  • Research Products

    (11 results)

All Other

All Publications (11 results)

  • [Publications] Y.Nagao;M.Ochiai: Bull.Inst.Chem.Res.Kyoto.Univ.63. 132-155 (1985)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y.Nagao;T.Ikeda;T.Inoue;M.Yagi;M.Shiro;E.Fujita: J.Org.Chem.50. 4072-4080 (1985)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y.Nagao;S.Sano;T.Miyasaka;M.Ochiai;K.Fuji;E.Fujita;H.Ishii: Nucleic Acids Research,Symposium Series. No.16. 37-40 (1985)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y.Nagao;E.Fujita;K.Inoue;M.Yamaki;S.Takagi;N.Sakamoto;N.Hotta: J.Pharmacobio-Dyn.8. -176 (1985)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y.Nagao;S.Sano;M.Ochiai;K.Fuji;S.Nishimoto;T.Kagiya;Y.Shibamoto;M.Abe;C.Murayama;T.Mori: J.Pharmacobio-Dyn.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] C.Murayama;Y.Nagao;S.Sano;M.Ochiai;K.Fufi;E.Fujita;T.Mori: Gann.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y. Nagao and M. Ochiai: "Design and Study of New Tumor Inhibitors" Bull. Inst. Chem. Res. Kyoto Univ.63. 132-155 (1985)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y. Nagao, T. Ikeda, T. Inoue, M. Yagi, M. Shiro, and E. Fujita: "J. Org. Chem." Highly Selective Nonenzymatic Chiral Induction into 3-Methylglutaric Acid and cis-4-Cyclohexen-1,2-ylenebis(acetic acid) Utilizing a Five-Membered Heterocycle 4(R)-MCTT. 50. 4072-4080 (1985)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y. Nagao, S. Sano, T. Miyasaka, M. Ochiai, K. Fuji, E. Fujita, and H. Ishii: "Evalution of the Affinity of New N Atom-Containing Tumor Inhibitors for Nucleic Acids" Nucleic Acids Research, Symposium Series. No.16. 37-40 (1985)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y. Nagao, E. Fujita, K. Inoue, M. Yamaki, S. Takagi, N. Sakamoto, and N. Hotta: "Synthesis of Aldose Reductase Inhibitors Having the Thiazolidine Skeleton" J. Pharmacobio-Dyn.8. s-176 (1985)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary
  • [Publications] Y. Nagao, S. Sano, M. Ochiai, K. Fuji, S. Nishimoto, T. Kagiya, Y. Shibamoto, M. Abe, C. Murayama, and T. Mori: "Synthetic Development of Hypoxic Cell Sencitizers Having 3-Nitrotriazole Moiety" J. Pharmacobio-Dyn.in press.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1986 Final Research Report Summary

URL: 

Published: 1987-03-31   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi